IJ Pharmaceutical Research
Scopus by Title (Ref)
1. Prognostic Implications of the Hemoglobin-Albumin-Lymphocyte-Platelet Index in Patients with Pemphigus
- Leetanaporn K. , et al.
2. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) is associated with inflammation and disease severity in pemphigus
- Peng X. , et al.
3. Antigen-Fc fusion therapy reduces severity of a model of pemphigus vulgaris without systemic immunosuppression
- Tavakolpour S. , et al.
4. Quantification of Apoptotic Bodies and Correlation of TNF-α & IL-2 Levels with Severity of Pemphigus Vulgaris
- Ravikumar R. , et al.
5. The Role of Interleukin-6 in Pemphigus Vulgaris
- Andrew K. , et al.
6. Serum interleukin-6 concentration in patients with pemphigus
- Van Thanh Le T. , et al.
7. Healthy individuals genetically at-risk for the development of Pemphigus vulgaris or Alopecia areata share disease-like cytokine dysregulation
- Schwartz R.R. , et al.
8. Cytokine profiling reveals HLA-linked Th2 and Th17 driven immune activation in pemphigus vulgaris patients and genetically susceptible healthy controls
- Schwartz R.R. , et al.
9. Clinical efficacy of inhaled corticosteroids in patients with coronavirus disease 2019: A living review and meta-analysis
- Yu S.Y. , et al.
10. Sarilumab (interleukin-6 receptor monoclonal antibody) for the treatment of pemphigus vulgaris
- Andrew K. , et al.
11. Expression of the Selected Proteins of JAK/STAT Signaling Pathway in Diseases with Oral Mucosa Involvement
- Ociepa K. , et al.
12. Safety and efficacy of corticosteroids in ARDS patients: a systematic review and meta-analysis of RCT data
- Chang X. , et al.
13. Topical sucralfate for treatment of mucocutaneous conditions: A systematic review on clinical evidences
- Abtahi-Naeini B. , et al.
14. No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial
- Jamaati H. , et al.
15. Pathogenic and protective roles of cytokines in pemphigus: A systematic review
- Tavakolpour S. , et al.
16. Recalcitrant pemphigus successfully treated with lenalidomide
- Zader J. , et al.
17. Ocular surface involvement in pemphigus vulgaris: An interdisciplinary review
- Memar O. , et al.
18. Phosphorylated p38 mitogen-activated kinase in patients with pemphigus vulgaris: A case-controlled study
- Sobeih S. , et al.
20. Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid
- Kowalski E. , et al.